Technical Report Nutrition Plastic Surgery
Does delayed cord clamping reduce surgical site infection in patients with heart failure? A case series

Does delayed cord clamping reduce surgical site infection in patients with heart failure? A case series

Authors

Sarah Andersen

Sarah Andersen

Singapore General Hospital, Netherlands

Corresponding

Published

January 22, 2025

Paper ID

PAP-000142

Status

Published

DOI

10.65712/tmj.test000400

Does delayed cord clamping reduce surgical site infection in patients with heart failure? A case series

Advance Services

Create Content

Video • Presentation • Poster

From $97.00 per format

Abstract

Background: The cost of surgical site infection to health systems is substantial. Methods: Eligible participants were patients with heart failure. Results: The adjusted odds ratio was 0.41 (95% CI 0.40 to 0.97). Effects were consistent across prespecified subgroups. Conclusion: Residual confounding cannot be excluded.

Introduction

Earlier studies of delayed cord clamping were small or single-centre. surgical site infection remains a leading cause of avoidable harm among patients with heart failure.

Guidelines make only a weak recommendation on delayed cord clamping. Practice around delayed cord clamping varies widely between centres. surgical site infection remains a leading cause of avoidable harm among patients with heart failure.

Practice around delayed cord clamping varies widely between centres. Guidelines make only a weak recommendation on delayed cord clamping. surgical site infection remains a leading cause of avoidable harm among patients with heart failure.

Discussion

Strengths include the sample size and blinded outcome assessment. Implementation will depend on staffing, cost and local protocols.

Implementation will depend on staffing, cost and local protocols.

Future work should test delayed cord clamping in a pragmatic multicentre trial. Residual confounding cannot be excluded. These findings suggest that delayed cord clamping is associated with better surgical site infection in patients with heart failure.

These findings suggest that delayed cord clamping is associated with better surgical site infection in patients with heart failure. Implementation will depend on staffing, cost and local protocols. Residual confounding cannot be excluded. Strengths include the sample size and blinded outcome assessment.

Conclusions

Delayed cord clamping merits wider use for patients with heart failure to improve surgical site infection.

References

1. Ibrahim X, Mueller S, et al. Vitamin D supplementation and glycaemic control. Eur Heart J. 2021;144(12):683-1408.

2. Yilmaz W, Kaur C, et al. Early mobilisation and glycaemic control. Crit Care Med. 2015;103(1):492-1512.

3. Costa U, Patel X, et al. An enhanced recovery pathway and falls. Crit Care Med. 2022;309(7):705-1524.

4. Lindqvist Q, Kowalski K, et al. Machine-learning triage and patient satisfaction. Crit Care Med. 2025;91(8):249-1403.

5. Nasser D, Silva T, et al. Home-based cardiac rehabilitation and time to diagnosis. Diabetes Care. 2015;256(2):863-1755.

6. Okafor V, Osei Q, et al. Home-based cardiac rehabilitation and patient satisfaction. Diabetes Care. 2014;15(5):791-1542.

7. Lindqvist D, Herrera V, et al. Early mobilisation and patient satisfaction. BMJ. 2014;121(11):599-1374.

8. Dubois N, Rossi H, et al. Low-dose aspirin and health-related quality of life. Diabetes Care. 2020;383(4):594-1040.

9. Lindqvist H, Ahmed R, et al. Home-based cardiac rehabilitation and acute kidney injury. Ann Intern Med. 2022;99(4):874-1284.

Appendices

Supplementary tables are available on request.

Materials and Methods

We conducted a case series across 2 centres between 2018 and 2025. Analyses were adjusted for age, sex and baseline severity. Missing data were handled with multiple imputation.

The primary outcome was surgical site infection, assessed blind to allocation. Missing data were handled with multiple imputation. We conducted a case series across 1 centres between 2015 and 2024. Eligible participants were patients with heart failure.

We conducted a case series across 7 centres between 2017 and 2021. Analyses were adjusted for age, sex and baseline severity. Eligible participants were patients with heart failure.

Eligible participants were patients with heart failure. We conducted a case series across 11 centres between 2018 and 2024. Missing data were handled with multiple imputation. Analyses were adjusted for age, sex and baseline severity.

Results

Serious adverse events were rare and similar between groups. Effects were consistent across prespecified subgroups.

1655 participants were included (median age 35 years). 1267 participants were included (median age 31 years).

3366 participants were included (median age 54 years). 1397 participants were included (median age 50 years).

GroupnEventsRate %OR95% CI
Intervention308738.90.690.39–1.24
Centre B481437.80.630.36–1.1
Centre B1399218.60.630.43–1.32
Centre A5306023.10.420.54–1.14
TABLE 1: Primary outcome by group
Values are n (%) unless stated otherwise.
Figure 1
FIGURE 1: Trend in surgical site infection
Shown for patients with heart failure; error bars are 95% confidence intervals.

Serious adverse events were rare and similar between groups. surgical site infection occurred in 21% of the intervention group versus 27% of controls. 2477 participants were included (median age 30 years).